Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate CancerAlexander W. Wyatt, Kim N., Fan Mo et al.|JAMA Oncology|2016Cited by 384
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesotheliomaRaunak Shrestha, Colin C. Collins|Genome Medicine|2019Cited by 135
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerPier‐Luc Clermont, Cheryl D. Helgason, Francesco Crea et al.|Clinical Epigenetics|2016Cited by 78
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation TherapyHimisha Beltran, Martin Gleave, Alexander W. Wyatt et al.|Clinical Cancer Research|2017Cited by 75